Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD. [electronic resource]
Producer: 20170809Description: 1469-76 p. digitalISSN:- 1178-2005
- Administration, Inhalation
- Adrenergic beta-2 Receptor Agonists -- administration & dosage
- Adult
- Aerosol Propellants -- adverse effects
- Aged
- Albuterol -- administration & dosage
- Bronchodilator Agents -- administration & dosage
- Double-Blind Method
- Drug Combinations
- Equipment Design
- Female
- Forced Expiratory Volume
- Humans
- Hydrocarbons, Fluorinated -- adverse effects
- India
- Ipratropium -- administration & dosage
- Lung -- drug effects
- Male
- Metered Dose Inhalers
- Middle Aged
- Muscarinic Antagonists -- administration & dosage
- Pulmonary Disease, Chronic Obstructive -- diagnosis
- Severity of Illness Index
- Therapeutic Equivalency
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.